Amendoim – Propriedades Funcionais - Abicab

Dra. Vanderlí Marchiori – Nutricionista e Fitoterapeuta – CRN3 – 3343
vanderlimarchiori@uol.com.br
44. ARTEEL GE, SCHROEDER P, SIES H. Reactions of peroxynitrite with cocoa procyanidin
oligomers. J Nutr, 130: 2100S-2104S, 2000.
45. BARONE JJ, Roberts HR. Caffeine consumption. Food Chem Toxicol, 34:119-129, 1996.
46. HAMMERSTONE JF, LAZARUS SA, SCHMITZ HH. Procyanidin content and variation in some
commonly consumed foods. J Nutr, 130:2086S-2092S, 2000.
47. KEEN, C.L. Chocolate: Food as Medicine/Medicine as Food. Journal of the American
College of Nutrition, 20(5), 436-439, 2001.
48. KNEKT P, JARVINEN R, REUNANEN A, MAATELA J. Flavonoid intake and coronary
mortality in Finland: a cohort study. BMJ, 312:478-481, 1996.
49. KONDO, K. HIRANO, R. MATSUMOTO, A. et al. Inibition of LDL oxidation by cocoa. Lancet,
348:1514, 1996.
50. KRIS-ETHERTONA, PM. KEENB, CL. Evidence that the antioxidant flavonoids in tea and
cocoa are beneficial for cardiovascular health. Curr Op Lipidol, 13:41-49, 2002.
51. KRIS-ETHERTONA, PM. MUSTAD, VA. Chocolate feeding studies: a novel approach for
evaluating the plasma lipid effects of stearic acid. Am J Clin Nutr, 60(suppl.): 1029S-
1036S, 1994.
52. KRIS-ETHERTONA, PM. et al. The role of fatty acid saturation on plasma lipids,
lipoproteins and apolipoproteins: I. Effects of whole food diets high in cocoa butter, olive
oil, soybean dairy butter and milk chocolate on the plasma lipids of young men,
Metabolism, 42:121-129, 1993.
53. NATSUME M; OSAKABE N; YAMAGISHI M; TAKIZAWA T; NAKAMURA T; MIYATAKE H;
HATANO, T; YOSHIDA T. Analyses of polyphenols in cacao liquor, cocoa, and chocolate by
normal-phase and reversed-phase HPLC. Biosci Biotechnol Biochem, 64(12):2581-7,
2000.
54. AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. Resoluções de 16 a 19 de abril de 1999.
55. AMERICAN DIETETIC ASSOCIATION. Position of the American Dietetic Association:
Functional Foods. Am J Diet Assoc, 99(10):1278-84., 1999.
56. BLACK R. Wheat Bran, Colon Cancer, and Breast Cancer – What Do We Have? What Do We
Need? Adv Exp Med Biol, 401:221, 1996.
57. BURR ML. Lessons from the Story of n-3 Fatty Acids. Am J Clin Nutr, 71(suppl):397S-8S,
2000.
58. CHEN WJL, ANDERSON JW, JENNINGS D. Propionate may mediate the
hypocholesterolemia effects of certain soluble plants fibers in cholesterol fed rats. Proc.
Soc. Exp. Biol. Med., 175: 215-218, 1984.
59. CONNOR WE. Importance of n-3 Fatty Acids in Health and Disease. Am J Clin Nutr,
71(suppl):171S-5S, 2000.
60. de SANTI C, PIETRABISSA A, MOSCA F, PACIFICI GM. Glucuronidation of
resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica,
30 (11): 1047-1054, 2000.
61. de SANTI C, PIETRABISSA A, MOSCA F, PACIFICI GM. Sulpnation of resveratrol, a
natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica,
30 (9): 857-866, 2000.
62. FONTECAVE e col. Resveratrol, a Remarkable Inhibitor of Ribonucleic Reductase. FEBS
Lett, 421:277-9, 1998.
63. FOOD AND NUTRITION BOARD, National Research Council. Recommended dietary
Allowances, 11 th ed. Washington: National Academy Press, 2010.
64. GORINSTEIN S. Comments on “Potential Explanation for the French Paradox” (Letter to
the editor). Nutrition Research, 19(11):1599-1602, 1999.
65. GRANT WB. An ecologic study of dietary links to prostate cancer. Altern. Med. Rev.,
4: 3, 162-169, 1999.
66. HARDY G. Nutraceuticals and Functional Foods: Introduction and Meaning. Nutrition,
16:688-9, 2000.
32